Insider trades

Marshall Fordyce, CEO of Vera Therapeutics VERA, has filed 0 purchases and 63 sales on the open market. Over the past 12 months that comes to a net sale of $3.1M. The latest trade was on 06/23.

Marshall Fordyce

President and CEO
First filing
23/02/17
Trades
151 trades
Buys / sales
0 / 63
12-month net buying
−$3.1M
Last trade
06/23

Trading activity

Transactions

Trade type
VERA
Open-market sale10b5-1 plan06/2306/2418,500 sh2 trades$37.93avg.$701,749−8.5%
VERA
Open-market sale10b5-1 plan05/1205/1318,500 sh2 trades$36.74avg.$679,766.45−7.9%
VERA
Open-market sale10b5-1 plan04/1404/1522,951 sh3 trades$44.05avg.$1,010,992.98−8.9%
Open-market sale02/2302/2516,925 sh$41.98$710,511.5−6.2%
VERA
Open-market sale10b5-1 plan25/02/21–25/02/2625/02/2719,688 sh3 trades$27.78avg.$546,859.82−8.8%
VERA
Open-market sale10b5-1 plan25/01/0825/01/1017,500 sh3 trades$41.74avg.$730,481.25−10.9%
VERA
Open-market sale10b5-1 plan24/12/1824/12/2017,500 sh5 trades$43.07avg.$753,678.77−16.9%
VERA
Open-market sale10b5-1 plan24/12/1124/12/1317,500 sh4 trades$46.94avg.$821,500.25−16.9%
VERA
Open-market sale10b5-1 plan24/11/2524/11/2719,375 sh5 trades$47.98avg.$929,534.45−18.4%
VERA
Open-market sale10b5-1 plan24/11/1324/11/1530,625 sh9 trades$49.50avg.$1,515,998.78−26.3%
VERA
Open-market sale10b5-1 plan24/10/2324/10/2519,375 sh4 trades$40.40avg.$782,667.15−5.9%
VERA
Open-market sale10b5-1 plan24/10/0924/10/1115,625 sh2 trades$38.24avg.$597,514−4.8%
VERA
Open-market sale10b5-1 plan24/09/2524/09/2723,125 sh11 trades$46.05avg.$1,064,833.18−7.0%
VERA
Open-market sale10b5-1 plan24/09/1124/09/1315,625 sh2 trades$37.50avg.$585,953.72−4.8%
VERA
Open-market sale10b5-1 plan24/08/2824/08/3030,320 sh4 trades$36.84avg.$1,117,084.9−9.0%
Open-market sale24/08/2124/08/2314,471 sh$39.76$575,366.96−4.3%
Open-market sale10b5-1 plan24/08/1424/08/1615,625 sh$37.56$586,875−4.4%
Open-market sale10b5-1 plan23/08/2123/08/235,210 sh$16.66$86,798.6−2.1%